LBA-03 Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial
DOI
オープンアクセス
収録刊行物
-
- Annals of Oncology
-
Annals of Oncology 27 ii140-, 2016-06-01
Elsevier BV